John Milligan
Chairman at PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Net worth: 4 M $ as of 31/03/2024
Profile
Dr. John F. Milligan is an Executive Chairman at 4D Molecular Therapeutics, Inc. and a Chairman at Pacific Biosciences of California, Inc. He is on the Board of Directors at Biotechnology Innovation Organization and Ohio Wesleyan University. Dr. Milligan was previously employed as a President by Pharmasset, Inc., a Director-Project Management by Hoffmann-La Roche, Inc., and a President, Chief Executive Officer & Director by Gilead Sciences, Inc. He received his undergraduate degree from Ohio Wesleyan University and a doctorate degree from the University of Illinois.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/04/2024 | 100,000 ( 0.20% ) | 3 M $ | 31/03/2024 | |
| 31/03/2024 | 110,000 ( 0.04% ) | 412 500 $ | 31/03/2024 |
John Milligan active positions
| Companies | Position | Start |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chairman | 14/09/2020 |
| 4D MOLECULAR THERAPEUTICS, INC. | Chairman | 01/08/2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 22/07/2011 |
| Ohio Wesleyan University | Chairman | - |
Former positions of John Milligan
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Executive Officer | 31/12/2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Training of John Milligan
| Ohio Wesleyan University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- John Milligan
